Analysts Set HCA Healthcare Inc (HCA) Price Target at $107.29

Shares of HCA Healthcare Inc (NYSE:HCA) have been given a consensus recommendation of “Hold” by the twenty-six ratings firms that are covering the stock, MarketBeat Ratings reports. Four research analysts have rated the stock with a sell rating, six have given a hold rating and sixteen have issued a buy rating on the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $107.29.

A number of equities research analysts have weighed in on HCA shares. Zacks Investment Research lowered HCA Healthcare from a “hold” rating to a “sell” rating in a research note on Wednesday, January 24th. William Blair restated a “hold” rating on shares of HCA Healthcare in a research note on Wednesday, January 24th. Wells Fargo started coverage on HCA Healthcare in a research note on Tuesday, January 30th. They set an “outperform” rating and a $116.00 price objective for the company. Cantor Fitzgerald restated a “buy” rating and set a $115.00 price objective on shares of HCA Healthcare in a research note on Tuesday, January 30th. Finally, Piper Jaffray restated a “hold” rating and set a $101.00 price objective on shares of HCA Healthcare in a research note on Tuesday, January 30th.

Get HCA Healthcare alerts:

In other news, insider Charles J. Hall sold 49,882 shares of HCA Healthcare stock in a transaction that occurred on Wednesday, February 21st. The stock was sold at an average price of $101.29, for a total value of $5,052,547.78. Following the completion of the transaction, the insider now owns 62,048 shares in the company, valued at approximately $6,284,841.92. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, major shareholder Thomas F. Frist, Jr. bought 28,650 shares of the firm’s stock in a transaction dated Tuesday, February 20th. The stock was purchased at an average price of $101.07 per share, with a total value of $2,895,655.50. Following the transaction, the insider now owns 389,855 shares in the company, valued at approximately $39,402,644.85. The disclosure for this purchase can be found here. 2.80% of the stock is currently owned by company insiders.

Large investors have recently added to or reduced their stakes in the stock. We Are One Seven LLC acquired a new position in HCA Healthcare during the 4th quarter valued at approximately $110,000. Parallel Advisors LLC boosted its position in HCA Healthcare by 76.2% during the 4th quarter. Parallel Advisors LLC now owns 1,337 shares of the company’s stock valued at $117,000 after purchasing an additional 578 shares during the period. Salem Investment Counselors Inc. acquired a new position in HCA Healthcare during the 4th quarter valued at approximately $130,000. Verition Fund Management LLC acquired a new position in HCA Healthcare during the 4th quarter valued at approximately $205,000. Finally, Bronfman E.L. Rothschild L.P. boosted its position in HCA Healthcare by 108.0% during the 4th quarter. Bronfman E.L. Rothschild L.P. now owns 2,425 shares of the company’s stock valued at $213,000 after purchasing an additional 1,259 shares during the period. Institutional investors and hedge funds own 72.52% of the company’s stock.

HCA Healthcare traded down $0.27, reaching $102.83, during mid-day trading on Thursday, according to MarketBeat Ratings. 1,214,131 shares of the company’s stock traded hands, compared to its average volume of 2,139,368. HCA Healthcare has a 1-year low of $71.18 and a 1-year high of $106.84. The company has a quick ratio of 1.17, a current ratio of 1.39 and a debt-to-equity ratio of -7.13. The firm has a market cap of $35.92 billion, a PE ratio of 15.60, a price-to-earnings-growth ratio of 1.00 and a beta of 0.48.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings data on Tuesday, May 1st. The company reported $2.33 earnings per share for the quarter, beating analysts’ consensus estimates of $2.07 by $0.26. HCA Healthcare had a negative return on equity of 55.50% and a net margin of 5.96%. The firm had revenue of $11.42 billion during the quarter, compared to analyst estimates of $11.29 billion. During the same quarter last year, the firm earned $1.74 EPS. HCA Healthcare’s quarterly revenue was up 7.5% on a year-over-year basis. analysts anticipate that HCA Healthcare will post 8.83 earnings per share for the current year.

The company also recently announced a quarterly dividend, which will be paid on Friday, June 29th. Stockholders of record on Friday, June 1st will be given a $0.35 dividend. The ex-dividend date of this dividend is Thursday, May 31st. This represents a $1.40 annualized dividend and a dividend yield of 1.36%. HCA Healthcare’s payout ratio is 21.24%.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Analyst Recommendations for HCA Healthcare (NYSE:HCA)